🇺🇸 FDA
Pipeline program

UB-221

UBP-A236-IgE

Phase 2 mab active

Quick answer

UB-221 for Chronic Spontaneous Urticaria is a Phase 2 program (mab) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Chronic Spontaneous Urticaria
Phase
Phase 2
Modality
mab
Status
active

Clinical trials